Segment disclosures

Company overview

바이오포트

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 16 retained observations 11 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consolidated

Consolidated And Separate Financial Statements

Source dimensions ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3021804032305 KRW20260814Open filing evidence
2026-01-01 – 2026-06-3043188583395 KRW20260814Open filing evidence
2026-01-01 – 2026-03-3121384551090 KRW20260515Open filing evidence
2025-01-01 – 2025-12-3170879747598 KRW20260318Open filing evidence
2025-07-01 – 2025-09-3019061881661 KRW20251114Open filing evidence
2025-01-01 – 2025-09-3055155647455 KRW20251114Open filing evidence
2025-04-01 – 2025-06-3019226279280 KRW20260814Open filing evidence
2025-01-01 – 2025-06-3036093765794 KRW20260814Open filing evidence
2025-01-01 – 2025-03-3116867486514 KRW20260515Open filing evidence
2024-01-01 – 2024-12-3173346275464 KRW20260318Open filing evidence
2024-07-01 – 2024-09-3017802871144 KRW20251114Open filing evidence
2024-01-01 – 2024-09-3054622870209 KRW20251114Open filing evidence
2024-04-01 – 2024-06-3017015355988 KRW20250814Open filing evidence
2024-01-01 – 2024-06-3036819999065 KRW20250814Open filing evidence
2023-01-01 – 2023-12-3168699069507 KRW20260318Open filing evidence
2022-01-01 – 2022-12-3160541344553 KRW20250610Open filing evidence